Shanghai Laishi: human thrombin has been approved for drug supplement application
Financial Associated Press, December 15 (Xinhua) - Shanghai Laishi announced that the company's human thrombin obtained the notice of approval of drug supplementary application.
This text is a result of machine translation.
Related companies：
In-depth
Technology
The Next Crossroad of SaaS: Vertical or Horizontal?
The SaaS (Software as a Service) industry has developed in China over nearly three decades. From horizontal SaaS formats to Vertical SaaS, great changes have taken place. Now the SaaS industry has entered a boom stage.
Sep 13, 2022 12:38 PM
Aug 29, 2022 05:45 PM
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Briefing Apr 02, 2022 05:34 PM
· Technology
China network security industry innovation and development alliance was officially established
Briefing Feb 17, 2022 07:29 PM
· Technology
Chinese mission to the European Union: express strong dissatisfaction and firm opposition to the European Parliament's arbitrary discussion of China's internal affairs
Briefing Feb 17, 2022 08:29 AM
· Technology
CITIC Securities: metauniverse is a future trend that cannot be underestimated, but it is still in the early stage of concept and marketing
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth